Written by
Mustafa Çelik
Mustafa Çelik Liv Hospital Content Team
Medically reviewed by

Related Doctors

Assoc. Prof. MD. Evrim Duman Liv Hospital Ulus Assoc. Prof. MD. Evrim Duman Radiation Oncology Asst. Prof. MD. Meltem Topalgökçeli Selam Liv Hospital Ulus Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology Prof. MD. Duygu Derin Liv Hospital Ulus Prof. MD. Duygu Derin Medical Oncology Prof. MD. Emre Merdan Fayda Liv Hospital Ulus Prof. MD. Emre Merdan Fayda Radiation Oncology Prof. MD. Meral Günaldı Liv Hospital Ulus Prof. MD. Meral Günaldı Medical Oncology Assoc. Prof. MD. Murat Ayhan Liv Hospital Vadistanbul Assoc. Prof. MD. Murat Ayhan Medical Oncology Prof. MD.  Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Assoc. Prof. MD. Erkan Kayıkçıoğlu Liv Hospital Bahçeşehir Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology Assoc. Prof. MD. Mine Dağgez Liv Hospital Bahçeşehir Assoc. Prof. MD. Mine Dağgez Gynecological Oncology Assoc. Prof. MD. Ozan Balakan Liv Hospital Bahçeşehir Assoc. Prof. MD. Ozan Balakan Medical Oncology MD. Taylan Bükülmez Liv Hospital Bahçeşehir MD. Taylan Bükülmez Radiation Oncology Op. MD. Alp Koray Kinter Liv Hospital Bahçeşehir Op. MD. Alp Koray Kinter Gynecological Oncology Prof. MD. Nuri Faruk Aykan Liv Hospital Bahçeşehir Prof. MD. Nuri Faruk Aykan Medical Oncology Prof. MD. Yasemin Altuner Torun Liv Hospital Bahçeşehir Prof. MD. Yasemin Altuner Torun Pediatric Hematology and Oncology Spec. MD. Vildan Kayku Liv Hospital Bahçeşehir Spec. MD. Vildan Kayku Medical Oncology Spec. MD. Özlem Doğan Liv Hospital Bahçeşehir Spec. MD. Özlem Doğan Medical Oncology Assoc. Prof. MD. Emir Çelik Liv Hospital Topkapı Assoc. Prof. MD. Emir Çelik Medical Oncology Assoc. Prof. MD. Muhammed Mustafa Atcı Liv Hospital Topkapı Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology Prof. MD. İrfan Çiçin Liv Hospital Topkapı Prof. MD. İrfan Çiçin Medical Oncology Assoc. Prof. MD.  Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Assoc. Prof. MD. Nazlı Topfedaisi Özkan Liv Hospital Ankara Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology Prof. MD. Fikret Arpacı Liv Hospital Ankara Prof. MD. Fikret Arpacı Medical Oncology Prof. MD. Gökhan Erdem Liv Hospital Ankara Prof. MD. Gökhan Erdem Medical Oncology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Prof. MD. Saadettin Kılıçkap Liv Hospital Ankara Prof. MD. Saadettin Kılıçkap Medical Oncology Prof. MD. Sadık Muallaoğlu Liv Hospital Ankara Prof. MD. Sadık Muallaoğlu Medical Oncology Spec. MD. Ender Kalacı Liv Hospital Ankara Spec. MD. Ender Kalacı Medical Oncology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Prof. MD. Fatih Teker Liv Hospital Gaziantep Prof. MD. Fatih Teker Medical Oncology Spec. MD. ELXAN MEMMEDOV Liv Bona Dea Hospital Bakü Spec. MD. ELXAN MEMMEDOV Medical Oncology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elkhan Mammadov Spec. MD. Elkhan Mammadov Medical Oncology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Spec. MD. Natavan Azizova Spec. MD. Natavan Azizova Medical Oncology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology
...
Views
Read Time
...
views
Read Time
How Long Can You Live With Skin Cancer and Untreated Stage 4 Melanoma?
How Long Can You Live With Skin Cancer and Untreated Stage 4 Melanoma? 2

When you get a melanoma diagnosis, you might wonder: What are my chances of survival? At Liv Hospital, we know how vital it is to offer clear and caring advice every step of the way.

New treatments for melanoma have made a big difference. They’ve helped patients, even those with stage 4 melanoma, live longer. Studies show that these new therapies have boosted five-year survival rates to 30-50% in some cases.

The type and stage of cancer, and whether you’re getting treatment, all affect how long you can live. We’re dedicated to giving top-notch care and support to patients from around the world. Our goal is to offer the best medical results and follow the latest academic guidelines.

Key Takeaways

  • Melanoma survival rates have improved with recent advancements in treatment.
  • Stage 4 melanoma patients have seen five-year survival rates rise to 30-50%.
  • The type and stage of cancer significantly influence life expectancy.
  • Treatment presence and type play a critical role in survival outcomes.
  • Liv Hospital provides extensive support for international patients.

Understanding Skin Cancer Types and Their Severity

types of skin cancer
How Long Can You Live With Skin Cancer and Untreated Stage 4 Melanoma? 3

It’s important to know the different types of skin cancer to choose the right treatment. Skin cancer falls into several categories, each with its own traits and severity levels.

Different Types of Skin Cancer

Skin cancer is mainly split into three types: basal cell carcinoma, squamous cell carcinoma, and melanoma. Each type has its own features and risk of spreading.

Basal Cell Carcinoma

Basal cell carcinoma is the most common skin cancer. It grows slowly and usually doesn’t spread to other parts of the body.

Squamous Cell Carcinoma

Squamous cell carcinoma grows faster than basal cell carcinoma. It can spread, but this is rare.

Melanoma

Melanoma is the most dangerous skin cancer. It can spread quickly to other parts of the body, like the lymph nodes, lungs, and brain.

Why Melanoma Is Particualrly Dangerous

Melanoma is aggressive and can spread fast. It’s important to catch it early to increase chances of survival.

Early detection and treatment are key for melanoma patients. We’ll look at what affects survival rates next.

Survival Rates for Different Skin Cancer Types

Survival rates for skin cancer change a lot based on the type and stage. We’ll look at the outlook for basal cell carcinoma, squamous cell carcinoma, and melanoma.

Basal Cell and Squamous Cell Carcinoma Prognosis

Basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) are common skin cancers. Both have high cure rates if caught early. BCC’s five-year survival rate is almost 100% because it rarely spreads.

For SCC, the five-year survival rate is about 90%. But, it can change based on where the cancer is and if it has spread.

Melanoma Survival Rates by Stage

Melanoma is the most dangerous skin cancer because it can spread fast. Survival rates for melanoma depend a lot on the stage at diagnosis.

Early Stage (0-II) Survival Statistics

Early-stage melanoma (stages 0-II) has a high five-year survival rate. It’s almost 100% for stages 0 and I. Even at stage II, the survival rate is good, from 80% to 95%, based on the tumor’s details.

Advanced Stage (III-IV) Survival Statistics

Advanced-stage melanoma (stages III-IV) has lower survival rates. At stage III, the five-year survival rate is between 40% and 78%, depending on lymph node involvement. Stage IV melanoma, with cancer in distant organs, has a worse outlook. The five-year survival rate is between 15% and 20%.

Knowing these survival rates shows how critical early detection and treatment are. If you’re worried about skin cancer, talk to a healthcare professional for advice and care.

How Long Can You Live With Skin Cancer: Factors That Influence Survival

Understanding what affects survival in skin cancer patients is key. When someone is diagnosed with skin cancer, many things can change their life expectancy. We’ll look at these factors to understand what affects survival rates.

Stage at Diagnosis

The stage of skin cancer diagnosis is very important. Early detection usually means better treatment outcomes. But, late diagnosis can lead to a worse prognosis because the cancer might spread.

Early detection is key to improving survival rates. For example, melanoma caught early has a much better survival rate than stage IV melanoma.

The American Cancer Society says the 5-year survival rate for melanoma is about 99% if caught early. But, this rate drops a lot as the disease gets worse. Knowing the stage helps plan the right treatment and predict the outcome.

Location and Characteristics of the Cancer

The location and type of skin cancer also matter a lot. Cancers in certain areas, like the face or scalp, can be harder to treat. The type of skin cancer, like melanoma, basal cell carcinoma, or squamous cell carcinoma, also affects survival. Melanoma, being the most aggressive form, requires prompt and aggressive treatment.

The thickness of the tumor and whether it has ulceration are also important. These factors influence survival.

Patient Age and Overall Health

Patient age and overall health are also key factors. Older patients might have a poorer prognosis due to weaker immune systems and other health issues. Younger patients usually have better survival rates because they are healthier and can handle treatments better. A thorough assessment of the patient’s health helps tailor the treatment plan. Other health conditions can also affect treatment success and survival.

It’s important for patients to work closely with their healthcare providers. This way, they can understand their prognosis and get a treatment plan that fits them. By considering these factors, healthcare providers can give more accurate predictions and effective treatments.

Early-Stage Melanoma: High Survival Rates and Prognosis

Early-Stage Melanoma
How Long Can You Live With Skin Cancer and Untreated Stage 4 Melanoma? 4

People with early-stage melanoma have a good chance of survival. Early detection is key to successful treatment and a better outcome.

Stage 0-II Melanoma Life Expectancy

For those with Stage 0-II melanoma, the outlook is bright. The five-year survival rate for localized melanoma is about 99% if caught early. This shows how vital early detection is.

StageFive-Year Survival Rate
Stage 099%
Stage I99%
Stage II80-90%

Treatment Options and Their Impact on Survival

There are many effective treatments for early-stage melanoma. These treatments greatly improve survival chances. Treatment plans often include surgery and other therapies.

Surgical Approaches

Surgery is the main treatment for early-stage melanoma. Wide local excision is a common method. It removes the melanoma and some normal skin around it. This helps ensure all cancer cells are gone, lowering the chance of it coming back.

Adjuvant Therapies

Adjuvant therapies are sometimes used to prevent melanoma from coming back. Immunotherapy and targeted therapy are examples. They can help improve the prognosis.

Stage 4 Melanoma: Understanding the Advanced Disease

Stage 4 melanoma is the most advanced form of skin cancer. It has spread to distant organs or lymph nodes. This makes treatment harder.

Progression to Stage 4

Melanoma turns into stage 4 when cancer cells spread through the body. They travel through the bloodstream or lymphatic system. This creates new tumors in other parts of the body.

Common Sites of Metastasis and Their Impact on Prognosis

Melanoma can spread to several organs. Each site affects the patient’s chances of survival differently. Knowing these sites is key to managing the disease.

Lung Metastasis

Lung metastasis is common in stage 4 melanoma. It can cause breathing problems. This makes treatment harder and affects survival chances.

Brain Metastasis

Brain metastases are tough to deal with. They can cause neurological symptoms and lower quality of life. Treatment options include surgery, radiation, and systemic therapies.

Liver and Bone Metastasis

Liver and bone metastases are also common. Liver involvement can cause metabolic issues. Bone metastases can lead to pain and fractures. Both need careful management to improve quality of life.

Site of MetastasisCommon SymptomsImpact on Prognosis
LungsCough, shortness of breathComplicates treatment, affects overall survival
BrainHeadaches, neurological deficitsSignificantly impacts quality of life, poor prognosis
LiverAbdominal pain, jaundiceAffects metabolic function, complicates treatment
BonesPain, risk of fracturesImpacts mobility, affects quality of life

Understanding stage 4 melanoma and its spread is vital for treatment. While survival chances are tough, research and new treatments offer hope. They aim to improve survival rates and quality of life.

Untreated Stage 4 Melanoma: Timeline and Progression

It’s important to know how untreated stage 4 melanoma progresses. We’ll look at how fast it can spread and what affects its speed. This info helps in making care and treatment choices.

How Quickly Untreated Melanoma Advances

Untreated stage 4 melanoma can spread quickly to other parts of the body. The speed of progression varies among individuals, based on several factors.

Factors Affecting Progression Speed

Several things can affect how fast stage 4 melanoma spreads. These include the cancer’s genetics, the patient’s health, and other medical conditions. Knowing these factors helps predict the disease’s spread.

Warning Signs of Rapid Progression

It’s key to recognize signs of fast progression early. Symptoms like severe pain, significant weight loss, and neurological changes are warning signs. Patients should seek medical help quickly if they notice these symptoms.

Expected Survival Without Medical Intervention

Survival rates for untreated stage 4 melanoma are generally low. Without treatment, the outlook is poor, with survival rates dropping sharply.

Statistical Outcomes

Statistics show that patients with untreated stage 4 melanoma usually live about 6-9 months. But, this time can vary a lot. It’s important to look at these stats with overall health and other factors in mind.

Individual Variation Factors

Things like age, health, and the melanoma’s characteristics can greatly affect survival without treatment. Every patient’s case is different, and these factors should be considered when talking about prognosis.

While these stats give a general idea, outcomes can vary a lot. Getting medical care is very important. Treatment can help improve survival chances and quality of life.

Modern Treatments Improving Stage 4 Melanoma Survival

New treatments have greatly improved survival chances for stage 4 melanoma patients. We’re seeing big changes in how this serious disease is treated. New therapies are showing great promise.

Immunotherapy Breakthroughs

Immunotherapy has changed the game for stage 4 melanoma. It uses the body’s immune system to fight cancer. This approach has shown great promise in improving patient outcomes.

Checkpoint Inhibitors

Checkpoint inhibitors are a key part of immunotherapy for stage 4 melanoma. Drugs like pembrolizumab and nivolumab help the immune system attack cancer cells better.

Combination Approaches

Using different immunotherapies together or with other treatments has shown even better results. For example, combining checkpoint inhibitors with other therapies has improved response rates and survival in stage 4 melanoma patients.

Targeted Therapies and Their Results

Targeted therapies have also played a big role in treating stage 4 melanoma. They target specific genetic mutations that cause cancer to grow. For instance, BRAF inhibitors are effective against melanomas with BRAF mutations.

Treatment TypeMechanismExample Drugs
Checkpoint InhibitorsRelease brakes on immune systempembrolizumab, nivolumab
BRAF InhibitorsTarget BRAF mutationsvemurafenib, dabrafenib

How Treatment Has Changed the Prognosis Landscape

New treatments have greatly changed the outlook for stage 4 melanoma patients. While it’s a serious disease, these therapies have improved survival rates and quality of life. As research continues, we expect even better treatments to come.

We’re hopeful about the future of stage 4 melanoma treatment. Ongoing research and clinical trials are promising to bring more innovative solutions.

Living With Advanced Melanoma: Quality of Life Considerations

Living with advanced melanoma means tackling both physical and emotional challenges. As the disease gets worse, patients face many hurdles. These include managing symptoms and dealing with the emotional impact of the diagnosis.

Palliative Care Options

Palliative care is key for improving life quality in advanced melanoma patients. It aims to ease symptoms, pain, and stress. Palliative care teams work with patients to manage their symptoms, boosting their overall well-being.

Some main parts of palliative care are:

  • Pain management
  • Symptom control
  • Emotional and psychological support
  • Spiritual care

Support Systems and Resources

Support systems and resources are vital for those with advanced melanoma. They include family, friends, support groups, and online resources. Connecting with others who get what you’re going through can offer comfort and advice.

Support SystemDescriptionBenefits
Family and FriendsEmotional support and practical helpReduced feelings of loneliness, assistance with daily tasks
Support GroupsConnecting with others experiencing similar challengesEmotional comfort, sharing of experiences and advice
Online ResourcesAccess to information, forums, and educational materialsInformed decision-making, community connection

Conclusion: The Importance of Early Detection and Treatment

It’s key to know how early detection and treatment can save lives. We’ve learned that how long you live with skin cancer depends a lot on when it’s found. Early treatment can make a big difference, while waiting too long can lead to serious problems.

Today, we have better treatments like immunotherapy and targeted therapies for advanced melanoma. But, the most important thing is catching it early. Spotting the signs of skin cancer and getting help fast can greatly improve your chances.

If you’re worried about skin cancer, learning about its signs and risks is a good start. You can find lots of helpful info on cancer warning signs. By staying informed and taking action, you can boost your chances of beating melanoma.

How long can you live with untreated stage 4 melanoma?

Living with untreated stage 4 melanoma varies a lot. It depends on many things. Generally, the outlook is not good, with survival ranging from a few months to over a year.

What are the survival rates for different types of skin cancer?

Basal cell and squamous cell carcinomas have high survival rates if caught early. They are often over 90%. Melanoma survival rates are different, with early stages much better than late stages.

How does the stage at diagnosis affect survival in skin cancer patients?

The stage at diagnosis is very important. Early-stage skin cancers, like melanoma, have much better survival rates. Catching it early is key to a better outcome.

What are the common sites of metastasis for stage 4 melanoma, and how do they impact prognosis?

Stage 4 melanoma often spreads to the lungs, brain, liver, and bones. Where it spreads and how much affects survival. Brain metastasis is often the worst.

How have modern treatments improved survival for stage 4 melanoma patients?

New treatments like immunotherapy and targeted therapies have greatly improved survival for stage 4 melanoma patients. They help the immune system fight cancer or target cancer mutations.

What role does palliative care play in managing advanced melanoma?

Palliative care is vital for advanced melanoma. It focuses on improving life quality. It deals with symptoms, emotional support, and other needs for complete care.

Can you survive melanoma skin cancer, and what factors influence survival?

Yes, survival is possible, mainly with early detection and treatment. Survival depends on the stage, cancer location and type, and overall health.

How quickly can untreated melanoma progress?

Untreated melanoma can grow fast. How fast it grows depends on the cancer’s aggressiveness and the patient’s health.

What are the treatment options for early-stage melanoma, and how do they impact survival?

Early-stage melanoma treatments include surgery and adjuvant therapies. These treatments greatly improve survival by removing the cancer and treating any remaining cells.

How long can you live with melanoma without treatment?

Without treatment, life expectancy varies a lot. For stage 4 melanoma, the outlook is generally poor. This highlights the need for early treatment.

References

  • AIM at Melanoma Foundation: https://www.aimatmelanoma.org/melanoma-101/how-melanoma-is-diagnosed/prognosis/
  • Cancer Research UK: https://www.cancerresearchuk.org/about-cancer/melanoma/survival
  • National Center for Biotechnology Information (NCBI) / PMC: https://pmc.ncbi.nlm.nih.gov/articles/PMC10796594/
  • Cancer Treatment Centers of America (CTCA): https://www.cancercenter.com/cancer-types/melanoma/types/metastatic-melanoma
i

Medical Disclaimer

The content on this page is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified healthcare provider regarding any medical conditions.

Book a Free Certified Online
Doctor Consultation

Clinics/branches
GDPR

We're Here to Help.
Get in Touch

Send us all your questions or requests, and our
expert team will assist you.

Our Doctors

Assoc. Prof. MD. Evrim Duman Radiation Oncology

Assoc. Prof. MD. Evrim Duman

Liv Hospital Ulus
Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology

Asst. Prof. MD. Meltem Topalgökçeli Selam

Liv Hospital Ulus
Prof. MD. Duygu Derin Medical Oncology

Prof. MD. Duygu Derin

Liv Hospital Ulus
Prof. MD. Emre Merdan Fayda Radiation Oncology

Prof. MD. Emre Merdan Fayda

Liv Hospital Ulus
Prof. MD. Mehmet Hilmi Doğu Hematology

Prof. MD. Mehmet Hilmi Doğu

Liv Hospital Ulus
Liv Hospital Bahçeşehir
Prof. MD. Meral Günaldı Medical Oncology

Prof. MD. Meral Günaldı

Liv Hospital Ulus
Assoc. Prof. MD. Murat Ayhan Medical Oncology

Assoc. Prof. MD. Murat Ayhan

Liv Hospital Vadistanbul
Prof. MD.  Itır Şirinoğlu Demiriz Hematology

Prof. MD. Itır Şirinoğlu Demiriz

Liv Hospital Vadistanbul
Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology

Prof. MD. Tülin Tıraje Celkan

Liv Hospital Vadistanbul
Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology

Assoc. Prof. MD. Erkan Kayıkçıoğlu

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Mine Dağgez Gynecological Oncology

Assoc. Prof. MD. Mine Dağgez

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Ozan Balakan Medical Oncology

Assoc. Prof. MD. Ozan Balakan

Liv Hospital Bahçeşehir
MD. Taylan Bükülmez Radiation Oncology

MD. Taylan Bükülmez

Liv Hospital Bahçeşehir
Op. MD. Alp Koray Kinter Gynecological Oncology

Op. MD. Alp Koray Kinter

Liv Hospital Bahçeşehir
Prof. MD. Nuri Faruk Aykan Medical Oncology

Prof. MD. Nuri Faruk Aykan

Liv Hospital Bahçeşehir
Prof. MD. Yasemin Altuner Torun Pediatric Hematology and Oncology

Prof. MD. Yasemin Altuner Torun

Liv Hospital Bahçeşehir
Spec. MD. Vildan Kayku Medical Oncology

Spec. MD. Vildan Kayku

Liv Hospital Bahçeşehir
Spec. MD. Özlem Doğan Medical Oncology

Spec. MD. Özlem Doğan

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Emir Çelik Medical Oncology

Assoc. Prof. MD. Emir Çelik

Liv Hospital Topkapı
Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology

Assoc. Prof. MD. Muhammed Mustafa Atcı

Liv Hospital Topkapı
Prof. MD. İrfan Çiçin Medical Oncology

Prof. MD. İrfan Çiçin

Liv Hospital Topkapı
Assoc. Prof. MD.  Ramazan Öcal Hematology

Assoc. Prof. MD. Ramazan Öcal

Liv Hospital Ankara
Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology

Assoc. Prof. MD. Nazlı Topfedaisi Özkan

Liv Hospital Ankara
Prof. MD. Fikret Arpacı Medical Oncology

Prof. MD. Fikret Arpacı

Liv Hospital Ankara
Prof. MD. Gökhan Erdem Medical Oncology

Prof. MD. Gökhan Erdem

Liv Hospital Ankara
Prof. MD. Meral Beksaç Hematology

Prof. MD. Meral Beksaç

Liv Hospital Ankara
Prof. MD. Oral Nevruz Hematology

Prof. MD. Oral Nevruz

Liv Hospital Ankara
Prof. MD. Saadettin Kılıçkap Medical Oncology

Prof. MD. Saadettin Kılıçkap

Liv Hospital Ankara
Prof. MD. Sadık Muallaoğlu Medical Oncology

Prof. MD. Sadık Muallaoğlu

Liv Hospital Ankara
Spec. MD. Ender Kalacı Medical Oncology

Spec. MD. Ender Kalacı

Liv Hospital Ankara
Assoc. Prof. MD. Fadime Ersoy Dursun Hematology

Assoc. Prof. MD. Fadime Ersoy Dursun

Liv Hospital Gaziantep
Prof. MD. Fatih Teker Medical Oncology

Prof. MD. Fatih Teker

Liv Hospital Gaziantep
Spec. MD. ELXAN MEMMEDOV Medical Oncology

Spec. MD. ELXAN MEMMEDOV

Liv Bona Dea Hospital Bakü
Spec. MD. Ceyda Aslan Hematology

Spec. MD. Ceyda Aslan

Spec. MD. Elkhan Mammadov Medical Oncology

Spec. MD. Elkhan Mammadov

Spec. MD. Elmir İsrafilov Hematology

Spec. MD. Elmir İsrafilov

Spec. MD. Minure Abışova Eliyeva Hematology

Spec. MD. Minure Abışova Eliyeva

Spec. MD. Natavan Azizova Medical Oncology

Spec. MD. Natavan Azizova

Need Help? Chat with our medical team

Let's Talk on WhatsApp

📌

Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.

or call us at +90 530 174 28 17